GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » Cyclically Adjusted Revenue per Share

Renhe Pharmacy Co (SZSE:000650) Cyclically Adjusted Revenue per Share : ¥3.44 (As of Mar. 2025)


View and export this data going back to 1996. Start your Free Trial

What is Renhe Pharmacy Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Renhe Pharmacy Co's adjusted revenue per share for the three months ended in Mar. 2025 was ¥0.704. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥3.44 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Renhe Pharmacy Co's average Cyclically Adjusted Revenue Growth Rate was 0.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Renhe Pharmacy Co was 26.40% per year. The lowest was 4.70% per year. And the median was 15.35% per year.

As of today (2025-05-31), Renhe Pharmacy Co's current stock price is ¥5.56. Renhe Pharmacy Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥3.44. Renhe Pharmacy Co's Cyclically Adjusted PS Ratio of today is 1.62.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Renhe Pharmacy Co was 12.44. The lowest was 1.52. And the median was 2.56.


Renhe Pharmacy Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Renhe Pharmacy Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renhe Pharmacy Co Cyclically Adjusted Revenue per Share Chart

Renhe Pharmacy Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.87 2.97 3.18 3.36 3.41

Renhe Pharmacy Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.42 3.42 3.43 3.41 3.44

Competitive Comparison of Renhe Pharmacy Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Renhe Pharmacy Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renhe Pharmacy Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renhe Pharmacy Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Renhe Pharmacy Co's Cyclically Adjusted PS Ratio falls into.


;
;

Renhe Pharmacy Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Renhe Pharmacy Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.704/115.1156*115.1156
=0.704

Current CPI (Mar. 2025) = 115.1156.

Renhe Pharmacy Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.537 99.500 0.621
201509 0.509 100.500 0.583
201512 0.652 100.600 0.746
201603 0.677 102.200 0.763
201606 0.731 101.400 0.830
201609 0.738 102.400 0.830
201612 0.772 102.600 0.866
201703 0.668 103.200 0.745
201706 0.776 103.100 0.866
201709 0.748 104.100 0.827
201712 0.948 104.500 1.044
201803 0.883 105.300 0.965
201806 0.943 104.900 1.035
201809 0.865 106.600 0.934
201812 0.870 106.500 0.940
201903 1.000 107.700 1.069
201906 0.980 107.700 1.047
201909 0.891 109.800 0.934
201912 0.797 111.200 0.825
202003 0.712 112.300 0.730
202006 0.861 110.400 0.898
202009 0.816 111.700 0.841
202012 0.906 111.500 0.935
202103 0.870 112.662 0.889
202106 0.846 111.769 0.871
202109 0.898 112.215 0.921
202112 0.951 113.108 0.968
202203 0.937 114.335 0.943
202206 0.893 114.558 0.897
202209 0.918 115.339 0.916
202212 0.931 115.116 0.931
202303 0.968 115.116 0.968
202306 0.947 114.558 0.952
202309 0.812 115.339 0.810
202312 0.867 114.781 0.870
202403 0.884 115.227 0.883
202406 0.805 114.781 0.807
202409 0.561 115.785 0.558
202412 0.669 114.893 0.670
202503 0.704 115.116 0.704

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Renhe Pharmacy Co  (SZSE:000650) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Renhe Pharmacy Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5.56/3.44
=1.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Renhe Pharmacy Co was 12.44. The lowest was 1.52. And the median was 2.56.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Renhe Pharmacy Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Renhe Pharmacy Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Renhe Pharmacy Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 998, Honggutan Road, Greenland Central Plaza, 18th Floor, Yuanchuang International, Zone B, Honggutan New District, Jiangxi Province, Nanchang, CHN, 330038
Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.
Executives
Yang Xiao Director
Kang Zhi Hua Supervisors
Mei Qiang Directors, executives
Yang Wen Long Director

Renhe Pharmacy Co Headlines

No Headlines